Table 1. Analysis of Long COVID (LC) in relation to vaccination status and number of SARS-CoV-2 infections among patients on chronic medication. Statistical comparisons are shown between groups receiving antihistamine treatment (AntiHm) or not (No AntiHm), stratified by whether vaccination occurred before (V pre-inf) or after (V post-inf) the first infection. A more detailed analysis, stratified by increasing number of chronic medications, is provided in Supplementary Material S1.
Protektive Wirkung von Antihistaminika gegen thrombotische Ereignisse und Long COVID
Eine große Real-World Datenanalyse (~193.000 Personen, 2020–2025) deutet darauf hin, dass Menschen, die regelmäßig Antihistaminika einnehmen, weniger thrombotische Ereignisse und fast keine …